LeMaitre Vascular, Inc. (LMAT) financial statements and ratios from SEC XBRL: revenue $249.60M (TTM), net margin 23.1%, revenue growth 13.5% YoY, P/E 28.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $249.60M |
| Net Margin | 23.1% |
| Revenue Growth (YoY) | 13.5% |
| EPS Growth (YoY) | 30.1% |
| FCF Growth (YoY) | 100.4% |
| P/E Ratio | 28.6 |
| EV / EBITDA | 19.6 |
| Price / Book | 4.48 |
| Price / Sales | 7.12 |
| FCF Yield | 5.5% |
| DCF Value (model) | $35.40 |
| DCF Upside vs Price | -57.0% |
| Altman Z-Score | 7.10 (safe) |
| Sector P/E (Healthcare) | 21.6 |
LMAT overview · LMAT earnings · LMAT KPIs · LMAT investor relations · LMAT ownership · LMAT peers · LMAT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.